domingo, 15 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 6, 2026

What's a Realistic Retirement Budget? I'm 55 With $620k Saved and $68k Income

View original at finance.yahoo.com
What's a Realistic Retirement Budget? I'm 55 With $620k Saved and $68k Income There are two common ways to think about a retirement budget: you can start with the lifestyle you want or the assets you have…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Using the 4% rule, if your goal is to withdraw $100,000 annually in retirement income your savings target would be roughly $2.5 million

    80% confidence
  • Earlier retirement generally increases exposure to inflation and longevity risk

    80% confidence
  • Some analysts note that current bond yields and market conditions may support different withdrawal assumptions than the 4% rule

    80% confidence
  • Savings held in a Roth account generally allow qualified withdrawals to be tax-free

    80% confidence
  • Social Security defines full retirement age as 67, when most people can first claim unreduced benefits

    80% confidence
  • Claiming Social Security at 62 can lower payments to roughly 70% of the full amount

    80% confidence
  • Delaying Social Security benefits to age 70 can reach about 124% of the full retirement age amount

    80% confidence
  • A 55-year-old with $620,000 in a 401(k) earning $68,000 per year and contributing 10% annually could reach about $1.69 million by age 67

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,580 documentos-fonte arquivados
Consulte estes dados → isubstrate.com